CS Medica AS (STU:8G8) Net Change in Cash : €-0.05 Mil (TTM As of Sep. 2024)

View and export this data going back to 2024. Start your Free Trial

What is CS Medica AS Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

CS Medica AS's Net Change in Cash for the three months ended in Sep. 2024 was €0.03 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Sep. 2024 was €-0.05 Mil.

CS Medica AS Net Change in Cash Historical Data

The historical data trend for CS Medica AS's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CS Medica AS Net Change in Cash Chart

CS Medica AS Annual Data

Trend

Sep19

Sep20

Sep21

Sep22

Sep23

Sep24

Net Change in Cash

Get a 7-Day Free Trial

0.09

1.30

-0.95

-0.05

-0.45

CS Medica AS Quarterly Data
	Sep19	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Net Change in Cash	Get a 7-Day Free Trial														-0.01	-0.24	0.02	0.13	0.03

CS Medica AS Net Change in Cash Calculation

CS Medica AS's Net Change in Cash for the fiscal year that ended in Sep. 2024 is calculated as

Net Change in Cash	=	Cash Flow from Operations	+	Cash Flow from Investing	+	Cash Flow from Financing	+	Effect of Exchange Rate Changes
	=	-1.117	+	-0.293	+	0.961	+	0
	=	-0.45

CS Medica AS's Net Change in Cash for the quarter that ended in Sep. 2024

Net Change in Cash = Cash Flow from Operations + Cash Flow from Investing + Cash Flow from Financing + Effect of Exchange Rate Changes

= -0.713 + -0.058 + 0.805 + 0

= 0.03

Net Change in Cash for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.05 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CS Medica AS Net Change in Cash Related Terms
Thank you for viewing the detailed overview of CS Medica AS's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

CS Medica AS Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » CS Medica AS (STU:8G8) » Definitions » Net Change in Cash

Comparable Companies

OSTO:PMDS XSAT:ZENI OSTO:PERP B OSTO:QLIFE XSAT:TENDO XSAT:IMS XSAT:PEXA B OSTO:BIOVIT XSAT:VSD B OSTO:CMH ABT SYK BSX MDT XTER:SHL EW SZSE:300760 DXCM XAMS:PHIA ZBH

Traded in Other Exchanges

N/A

Address

Indiakaj 10, Copenhagen, DNK, 2100

Website

https://www.cs-medica.com

CS Medica AS is engaged in developing, manufacturing, and commercializing over-the-counter medical device products containing cannabinoids currently focusing on cannabidiol for the treatment of psoriasis and arthritis. It operates in two business segments such as GalaxaPharma A/S responsible for distribution operation for marketing and sales direct-to-consumer, to retailers, and e-tail and CANNORDIC A/S is engaged in research and development, establishing of global business contracts, supply of CBD ingredients and production of finished products.

CS Medica AS Headlines

No Headlines